Recently, they were successfully used for the long-term expression of a gene encoding an alanine-glyoxylate aminotransferase (AGT) in patients with primary hyperoxaluria type 1 (PH1), a rare kidney disorder that causes recurrent kidney stones (90). The gene discussed is AGXT; the disease is primary hyperoxaluria type 1.